Personalized management and decision-making for non-ST-segment elevation acute coronary syndrome in vulnerable populations [0.03%]
脆弱人群非ST段抬高型急性冠脉综合征的个体化管理与决策中国专家共识
Pablo Díez-Villanueva,César Jiménez-Méndez,Pedro Cepas-Guillén et al.
Pablo Díez-Villanueva et al.
Introduction: Acute coronary syndromes (ACS) remain the leading cause of mortality in developed countries, particularly affecting older adults. Managing vulnerable patients - particularly those who are frail or have signi...
How important is measuring hemodynamic parameters for risk stratification in acute pulmonary embolism patients? [0.03%]
急性肺栓塞患者血流动力学参数测定对风险评估的重要性分析
Marco Zuin
Marco Zuin
Introduction: Acute pulmonary embolism (PE) is a cardiovascular life-threatening condition associated with significant morbidity and mortality worldwide. Hemodynamic instability is a critical determinant of outcomes in PE...
Thirst in heart failure: a neglected symptom with profound implications for patient management and quality of life [0.03%]
心力衰竭中的口渴症状：一个被忽视但对患者管理和生活质量有重大影响的指标
Razieh Parizad,Juniali Hatwal,Ajit Brar et al.
Razieh Parizad et al.
Introduction: Thirst is a common yet underrecognized symptom in patients with heart failure (HF), exerting a significant impact on disease management, treatment adherence, and quality of life (QoL). Approximately 65-75% o...
Improving on current guidelines for aspirin-free strategies after percutaneous coronary intervention and future perspectives [0.03%]
冠脉介入治疗后无阿司匹林策略的当前指南改进及未来展望
Antonio Landi,Michele A Karaboue,Leonardo De Luca
Antonio Landi
Introduction: In the last decade, technological advancements in procedural devices and techniques as the increasing recognition of the prognostic relevance of bleeding after percutaneous coronary intervention (PCI) paved ...
Cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries (MINOCA): current and evolving perspectives [0.03%]
非冠状动脉阻塞性心肌梗死(MINOCA)的心肌磁共振成像：现状与未来展望
Michele Di Leo,Nicolò Vasumini,Angelo Maida et al.
Michele Di Leo et al.
Introduction: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) represents a diagnostic challenge, requiring the exclusion of non-ischemic causes such as myocarditis, Takotsubo syndrome, and cardiomyop...
The role of enhanced stent visualization imaging in percutaneous coronary intervention: a systematic review of efficacy and clinical outcomes [0.03%]
冠状动脉介入治疗中优化支架显影的影像学作用：系统性回顾及临床疗效分析
Vibhootee Sant Bakshsingh,Shawmendra S Bundhoo,Majd B Protty
Vibhootee Sant Bakshsingh
Introduction: Coronary artery disease (CAD) is a major global cause of morbidity and mortality. Percutaneous coronary intervention (PCI) is central to its management, and optimal stent deployment is critical. This systema...
Association between non-dipper blood pressure pattern and coronary artery disease burden in hypertensive patients [0.03%]
高血压患者中非 dipping 型血压与冠状动脉疾病的关系
Ozkan Bekler,Alparslan Kurtul
Ozkan Bekler
Background: Non-dipper blood pressure (BP) patterns are associated with increased cardiovascular risk, but their relationship to coronary artery disease (CAD) complexity remains unclear. This study evaluated whether a non...
Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed [0.03%]
降低低密度脂胆固醇的新疗法：实现其他方法未能达到的血脂目标以预防动脉粥样硬化性心血管疾病
Artur Dziewierz,Beata Bobrowska,Witold Streb et al.
Artur Dziewierz et al.
Introduction: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global morbidity and mortality, with elevated low-density lipoprotein cholesterol (LDL-C) established as a primary causal factor. Des...
Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed [0.03%]
新型降低低密度脂胆固醇疗法用于动脉粥样硬化性心血管疾病的一级预防——探索他人未及的靶点达标路径
Artur Dziewierz,Beata Bobrowska,Witold Streb et al.
Artur Dziewierz et al.
Introduction: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global morbidity and mortality, with elevated low-density lipoprotein cholesterol (LDL-C) established as a primary causal factor. Des...
How can cholesterol efflux capacity be used as a risk factor for atherosclerotic cardiovascular disease? [0.03%]
胆固醇流出能力可作为动脉粥样硬化性心血管疾病的危险因素吗？
Masatsune Ogura
Masatsune Ogura
Introduction: High-density lipoprotein cholesterol (HDL-C) has long been regarded as 'good cholesterol,' but clinical trials and epidemiological studies have demonstrated that simply raising HDL-C levels does not reduce c...